INS and Hyperglycemia: Thus, the addition of Lixisenatide to insulin glargine improved overall and post-prandial hyperglycemia and is worth considering as an alternative to prandial insulin for patients who do not achieve HbA1c goals with newly initiated basal insulin [132].